A new trading day began on Tuesday, with Revolution Medicines Inc (NASDAQ: RVMD) stock price up 0.53% from the previous day of trading, before settling in for the closing price of $47.04. RVMD’s price has ranged from $23.51 to $62.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 11.11% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 9.81%. With a float of $152.85 million, this company’s outstanding shares have now reached $167.75 million.
In an organization with 378 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -17912.67%, operating margin of -88031.94%, and the pretax margin is -76377.09%.
Revolution Medicines Inc (RVMD) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Revolution Medicines Inc is 16.18%, while institutional ownership is 81.75%. The most recent insider transaction that took place on Dec 05 ’24, was worth 59,999,962. In this transaction Director of this company bought 1,304,347 shares at a rate of $46.00, taking the stock ownership to the 2,096,612 shares. Before that another transaction happened on Nov 15 ’24, when Company’s General Counsel sold 2,554 for $55.13, making the entire transaction worth $140,811. This insider now owns 43,080 shares in total.
Revolution Medicines Inc (RVMD) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.99 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.81% per share during the next fiscal year.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Here are Revolution Medicines Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11653.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.59, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -3.97 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Let’s dig in a bit further. During the last 5-days, its volume was 3.33 million. That was better than the volume of 1.4 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 9.98%. Additionally, its Average True Range was 2.47.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 32.54%, which indicates a significant increase from 8.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.82% in the past 14 days, which was higher than the 43.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $52.17, while its 200-day Moving Average is $42.34. However, in the short run, Revolution Medicines Inc’s stock first resistance to watch stands at $48.46. Second resistance stands at $49.63. The third major resistance level sits at $50.35. If the price goes on to break the first support level at $46.57, it is likely to go to the next support level at $45.85. Assuming the price breaks the second support level, the third support level stands at $44.68.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
With a market capitalization of 8.62 billion, the company has a total of 168,219K Shares Outstanding. Currently, annual sales are 11,580 K while annual income is -436,370 K. The company’s previous quarter sales were 0 K while its latest quarter income was -156,290 K.
